Caladrius Biosciences Inc...

NASDAQ: CLBS · Real-Time Price · USD
0.43
-0.08 (-16.05%)
At close: Sep 15, 2022, 4:00 AM

Caladrius Biosciences Revenue Breakdown

Period Ending Dec 31, 2016
PCT Segment Revenue 35.27M
PCT Segment Revenue Growth n/a
R&D Segment Revenue 14K
R&D Segment Revenue Growth n/a

Revenue by Geography

Period Ending Dec 31, 2012
Regenerative Medicine - China Segment Revenue 52.3K
Regenerative Medicine - China Segment Revenue Growth n/a

Operating Expense Breakdown

Period Ending Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 3.48M 3.34M 2.7M 2.84M 2.82M 3.01M 2.54M 2.32M 2.47M 2.56M 2.31M 2.07M 2.36M 2.55M 2.29M 2.06M 2.15M 2.9M 2.67M 2.94M 3.43M 5.95M 4.27M 4.94M 4.71M 6.46M 5.03M 5.15M 8.74M 11.09M
Selling, General, and Administrative Revenue Growth +4.16% +23.82% -5.07% +0.89% -6.38% +18.55% +9.39% -6.18% -3.28% +10.50% +11.94% -12.30% -7.67% +11.60% +11.01% -3.96% -25.89% +8.55% -9.33% -14.27% -42.30% +39.19% -13.41% +4.90% -27.13% +28.29% -2.20% -41.08% -21.21% n/a
Research and Development Revenue 3.24M 3.28M 4.15M 4.13M 4.33M 5.08M 2.91M 3.03M 1.82M 1.5M 2.77M 3M 2.99M 2.04M 1.51M 1.7M 2.12M 2.26M 4.65M 3.19M 4.28M 3.46M 2.57M 2.63M 4.03M 5.88M 3.18M 6.32M 7.6M 6.8M
Research and Development Revenue Growth -1.19% -21.01% +0.61% -4.71% -14.72% +74.61% -4.03% +66.61% +21.28% -45.83% -7.89% +0.54% +46.61% +35.16% -11.37% -19.85% -6.17% -51.37% +45.97% -25.50% +23.53% +34.55% -2.16% -34.69% -31.45% +84.84% -49.66% -16.91% +11.72% n/a